X-15522394-T-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_203281.3(BMX):​c.559T>C​(p.Ser187Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,210,497 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 43 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000098 ( 0 hom. 37 hem. )

Consequence

BMX
NM_203281.3 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.26

Publications

1 publications found
Variant links:
Genes affected
BMX (HGNC:1079): (BMX non-receptor tyrosine kinase) This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038844317).
BS2
High Hemizygotes in GnomAd4 at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMXNM_203281.3 linkc.559T>C p.Ser187Pro missense_variant Exon 7 of 19 ENST00000348343.11 NP_975010.1 P51813

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMXENST00000348343.11 linkc.559T>C p.Ser187Pro missense_variant Exon 7 of 19 1 NM_203281.3 ENSP00000308774.6 P51813

Frequencies

GnomAD3 genomes
AF:
0.000116
AC:
13
AN:
112412
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000945
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000225
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000819
AC:
15
AN:
183079
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000172
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.0000984
AC:
108
AN:
1098032
Hom.:
0
Cov.:
32
AF XY:
0.000102
AC XY:
37
AN XY:
363426
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26394
American (AMR)
AF:
0.0000284
AC:
1
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19379
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30197
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54137
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40532
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4135
European-Non Finnish (NFE)
AF:
0.000122
AC:
103
AN:
841966
Other (OTH)
AF:
0.0000651
AC:
3
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000116
AC:
13
AN:
112465
Hom.:
0
Cov.:
23
AF XY:
0.000173
AC XY:
6
AN XY:
34639
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31005
American (AMR)
AF:
0.0000943
AC:
1
AN:
10600
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2737
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6177
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000225
AC:
12
AN:
53293
Other (OTH)
AF:
0.00
AC:
0
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.539
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000729
Hom.:
1
Bravo
AF:
0.0000604
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 30, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.559T>C (p.S187P) alteration is located in exon 7 (coding exon 6) of the BMX gene. This alteration results from a T to C substitution at nucleotide position 559, causing the serine (S) at amino acid position 187 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
14
DANN
Benign
0.85
DEOGEN2
Benign
0.11
T;T;T
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.45
.;.;T
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.039
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
1.3
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.76
N;N;N
REVEL
Benign
0.18
Sift
Benign
0.31
T;T;T
Sift4G
Benign
0.28
T;T;T
Polyphen
0.0010
B;B;B
Vest4
0.19
MVP
0.54
MPC
0.43
ClinPred
0.028
T
GERP RS
3.4
Varity_R
0.15
gMVP
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202245028; hg19: chrX-15540517; API